ORGN executed a 1:30 reverse stock split while suffering severe financial deterioration with operating losses tripling to $259M and revenue declining 40%.
The reverse stock split from 149M to 5.4M shares outstanding combined with massive financial losses suggests potential delisting concerns and significant shareholder dilution protection measures. The company's fundamental business performance has deteriorated dramatically, indicating potential viability issues that required immediate stock price support through the reverse split mechanism.
ORGN's financial position deteriorated across virtually all metrics, with operating losses exploding from $84.9M to $259.1M while revenue collapsed 40% to $18.9M, indicating severe operational challenges. The balance sheet contracted significantly with total assets falling 58% to $157.7M and stockholders' equity declining 69% to $104.2M, while cash burned down 41% to $32.9M despite improved operating cash flow. The only positive signal was increased capital expenditures of $30.2M suggesting continued investment, but this was overshadowed by the company's overall financial distress requiring emergency measures like the reverse stock split.
Capital expenditure jumped 237.4% — major investment cycle underway; assess returns on deployment.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Net income declined 198.3% — review whether driven by operations, interest costs, or non-recurring items.
Current liabilities surged 127.4% — significant near-term obligations; verify ability to meet short-term debt.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Total assets contracted 58.3% — asset sales, write-downs, or balance sheet optimization underway.
Current assets declined 41.9% — monitor working capital adequacy and short-term liquidity.
Cash declined 41.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Revenue declined 39.5% — significant demand weakness or market share loss warrants investigation.
Operating cash flow surged 35.5% — exceptional cash generation, highest quality earnings signal.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →